Biden And The FDA Push New Chemical Abortion Protocols That Endanger Women

President Biden will use all the institutional power of the federal Government to encourage access to harmful chemical abortion pills.

On Sunday, the White House released a memo directing the Department of Health and Human Services and the Department of Homeland Security to provide guidance for patients and pharmacies on how to obtain chemical abortion pills in countries where they are illegal or restricted. President Obama also asked federal agencies and departments to make recommendations for the removal of illegal abortions. “potential barriers” To access abortion pills.

The U.S. Food and Drug Administration (FDA), had earlier this month removed the requirement that abortion pills must be administered in person by qualified medical staff. It also moved to allow pharmacies to fill prescriptions for the pill — a seismic change in policy that could soon turn your local pharmacy into an abortion pill dispensary.

Both changes endanger women’s health.

Two different drugs are required to induce abortion with pills. The unborn child is usually killed by the first drug, mifepristone. It blocks essential progesterone. The second drug, misoprostol, induces contractions to expel the unborn child from its mother’s womb. Both drugs come with risks.

The FDA approved mifepristone in 2000 but considered the drug’s risk profile so high as to warrant special heightened monitoring and risk management practices. The agency, therefore, established a Risk Evaluation and Mitigation Strategy (REMS) program — a strict protocol governing the administration of mifepristone.

Doctors had to fulfill special requirements in order to prescribe the drug. These required doctors to be able to accurately determine the gestational age and diagnose ectopic pregnancies. They also had to be able to perform a surgical procedure to remove incomplete abortion tissue or give access to emergency resuscitation treatments if needed. In order to administer the two-drug, abortion pill regimen, REMS initially required that the patient make two visits in person. A mandatory follow-up visit was also required in order to avoid serious complications. In the beginning, doctors were required by FDA to report any serious adverse events.

In 2016, FDA allowed non-physicians to start prescribing mifepristone. They also discontinued the requirement that an abortion be performed in a doctor’s office. However, the requirement that the pill be administered in-person by a certified prescriber was not eliminated.

The pandemic changed all that. The FDA temporarily suspended in-person administration of the pills and required follow-up visits. The FDA’s January update of the mifepristone REMS makes these pandemic-era changes permanent.

FDA also plans to allow pharmacies to fill abortion prescriptions. CVS, Walgreens, and Honeybee Health are the retail pharmacy giants. announced They intend to sell them in countries where abortion is legal.

This is all bad news not just for the unborn, but also for women’s health.

There are risks in removing mandatory follow-up exams

The mandatory follow-up visit requirement was removed.

*As an Amazon Associate I earn from qualifying purchases